Q&A: Cytiva’s Pierre-Alain Ruffieux on Scaling Cell and Gene Therapy Manufacturing for Global Access
Cytiva’s Pierre-Alain Ruffieux discusses standardization, regionalization, talent gaps, and regulatory pathways shaping advanced biomanufacturing’s future ahead of BIO 2026.
